| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
* Turku Center for Biotechnology, University of Turku and Åbo Akademi University,
Department of Biology, Åbo Akademi University, BioCity, and
Department of Biology, Laboratory of Animal Physiology, University of Turku, Turku, Finland
Fas ligand and TNF-related apoptosis-inducing ligand (TRAIL) induce apoptosis in many different cell types. Jurkat T cells die rapidly by apoptosis after treatment with either ligand. We have previously shown that mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) can act as a negative regulator of apoptosis mediated by the Fas receptor. In this study we examined whether MAPK/ERK can also act as a negative regulator of apoptosis induced by TRAIL. Activated Jurkat T cells were efficiently protected from TRAIL-induced apoptosis. The protection was shown to be MAPK/ERK dependent and independent of protein synthesis. MAPK/ERK suppressed TRAIL-induced apoptosis upstream of the mitochondrial amplification loop because mitochondrial depolarization and release of cytochrome c were inhibited. Furthermore, caspase-8-mediated relocalization and activation of Bid, a proapoptotic member of the Bcl family, was also inhibited by the MAPK/ERK signaling. The protection occurred at the level of the apoptotic initiator caspase-8, as the cleavage of caspase-8 was inhibited but the assembly of the death-inducing signaling complex was unaffected. Both TRAIL and Fas ligand have been suggested to regulate the clonal size and persistence of different T cell populations. Our previous results indicate that MAPK/ERK protects recently activated T cells from Fas receptor-mediated apoptosis during the initial phase of an immune response before the activation-induced cell death takes place. The results of this study show clearly that MAPK/ERK also participates in the inhibition of TRAIL-induced apoptosis after T cell activation.
This article has been cited by other articles:
|
|
 |
|
  D. Chiron, C. Pellat-Deceunynck, M. Maillasson, R. Bataille, and G. Jego Phosphorothioate-Modified TLR9 Ligands Protect Cancer Cells against TRAIL-Induced Apoptosis J. Immunol., October 1, 2009; 183(7): 4371 - 4377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Guicciardi and G. J. Gores Life and death by death receptors FASEB J, June 1, 2009; 23(6): 1625 - 1637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Yoon, M.-J. Kim, M.-T. Park, J.-Y. Byun, Y.-H. Choi, H.-S. Yoo, Y.-M. Lee, J.-W. Hyun, and S.-J. Lee Activation of p38 Mitogen-Activated Protein Kinase Is Required for Death Receptor-Independent Caspase-8 Activation and Cell Death in Response to Sphingosine Mol. Cancer Res., March 1, 2009; 7(3): 361 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Voisin, A. El Firar, C. Rouyer-Fessard, V. Gratio, and M. Laburthe A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism FASEB J, June 1, 2008; 22(6): 1993 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Liao, S.-M. Hsu, and P.-H. Huang ARMS Depletion Facilitates UV Irradiation Induced Apoptotic Cell Death in Melanoma Cancer Res., December 15, 2007; 67(24): 11547 - 11556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. O'Brien, M. A. Richardson, S. F. Mehrbod, D. T. Berg, B. Gerlitz, A. Gupta, and B. W. Grinnell Activated Protein C Decreases Tumor Necrosis Factor Related Apoptosis-Inducing Ligand by an EPCR- Independent Mechanism Involving Egr-1/Erk-1/2 Activation Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2634 - 2641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Richter and D. J. Topham The {alpha}1beta1 Integrin and TNF Receptor II Protect Airway CD8+ Effector T Cells from Apoptosis during Influenza Infection J. Immunol., October 15, 2007; 179(8): 5054 - 5063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Baritaki, A. Katsman, D. Chatterjee, K. C. Yeung, D. A. Spandidos, and B. Bonavida Regulation of Tumor Cell Sensitivity to TRAIL-Induced Apoptosis by the Metastatic Suppressor Raf Kinase Inhibitor Protein via Yin Yang 1 Inhibition and Death Receptor 5 Up-Regulation J. Immunol., October 15, 2007; 179(8): 5441 - 5453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Guicciardi, S. F. Bronk, N. W. Werneburg, and G. J. Gores cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1337 - G1346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Meinander, T. S. Soderstrom, A. Kaunisto, M. Poukkula, L. Sistonen, and J. E. Eriksson Fever-Like Hyperthermia Controls T Lymphocyte Persistence by Inducing Degradation of Cellular FLIPshort J. Immunol., March 15, 2007; 178(6): 3944 - 3953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nekrasova, C. Shive, Y. Gao, K. Kawamura, R. Guardia, G. Landreth, and T. G. Forsthuber ERK1-Deficient Mice Show Normal T Cell Effector Function and Are Highly Susceptible to Experimental Autoimmune Encephalomyelitis J. Immunol., August 15, 2005; 175(4): 2374 - 2380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bhattacharya, R. M. Ray, and L. R. Johnson Prevention of TNF-{alpha}-induced apoptosis in polyamine-depleted IEC-6 cells is mediated through the activation of ERK1/2 Am J Physiol Gastrointest Liver Physiol, March 1, 2004; 286(3): G479 - G490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Fernandez, A. M. Ramos, P. Sancho, D. Amran, E. de Blas, and P. Aller 12-O-Tetradecanoylphorbol-13-acetate May Both Potentiate and Decrease the Generation of Apoptosis by the Antileukemic Agent Arsenic Trioxide in Human Promonocytic Cells: REGULATION BY EXTRACELLULAR SIGNAL-REGULATED PROTEIN KINASES AND GLUTATHIONE J. Biol. Chem., January 30, 2004; 279(5): 3877 - 3884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-T. Park, J.-A Choi, M.-J. Kim, H.-D. Um, S. Bae, C.-M. Kang, C.-K. Cho, S. Kang, H. Y. Chung, Y.-S. Lee, et al. Suppression of Extracellular Signal-related Kinase and Activation of p38 MAPK Are Two Critical Events Leading to Caspase-8- and Mitochondria-mediated Cell Death in Phytosphingosine-treated Human Cancer Cells J. Biol. Chem., December 12, 2003; 278(50): 50624 - 50634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zanin-Zhorov, R. Hershkoviz, I. Hecht, L. Cahalon, and O. Lider Fibronectin-Associated Fas Ligand Rapidly Induces Opposing and Time-Dependent Effects on the Activation and Apoptosis of T Cells J. Immunol., December 1, 2003; 171(11): 5882 - 5889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Gober, C. C. Smith, K. Ueda, J. A. Toretsky, and L. Aurelian Forced Expression of the H11 Heat Shock Protein Can Be Regulated by DNA Methylation and Trigger Apoptosis in Human Cells J. Biol. Chem., September 26, 2003; 278(39): 37600 - 37609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Jia, C. Yu, M. Rahmani, G. Krystal, E. A. Sausville, P. Dent, and S. Grant Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF/MEK- and AKT-related pathways Blood, September 1, 2003; 102(5): 1824 - 1832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zhang, J. Hirahashi, X. Cullere, and T. N. Mayadas Elucidation of Molecular Events Leading to Neutrophil Apoptosis following Phagocytosis: CROSS-TALK BETWEEN CASPASE 8, REACTIVE OXYGEN SPECIES, AND MAPK/ERK ACTIVATION J. Biol. Chem., August 1, 2003; 278(31): 28443 - 28454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ibata-Ombetta, T. Idziorek, P.-A. Trinel, D. Poulain, and T. Jouault Candida albicans Phospholipomannan Promotes Survival of Phagocytosed Yeasts through Modulation of Bad Phosphorylation and Macrophage Apoptosis J. Biol. Chem., April 4, 2003; 278(15): 13086 - 13093. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
